麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 2 2015

Full Issue

FDA Commissioner Margaret Hamburg Ends 6-Year Run

Elsewhere, the Food and Drug Administration issues guidance on how to study abuse-deterrent painkillers, and measles vaccinations are up after a recent outbreak scare.

Margaret Hamburg ended her run this week as one of the longest serving Food and Drug Administration commissioners in recent decades. NPR's Robert Siegel speaks with her about her accomplishments and challenges while in office. (4/1)

The Food and Drug Administration released long-awaited guidance on how it wants drugmakers to study the efficacy of abuse-deterrent painkillers, but has punted on the thorny issue of generics for now. The document comes more than two years after the agency issued draft guidance, amid mounting pressure from Congress to speed up the process. An amendment from Rep. Hal Rogers, R-Ky., in the year-end spending package called for the agency to release the guidance by June of this year or face the removal of $20 million in funds for salaries and expenses from the commissioner鈥檚 office. (Gustin, 4/1)

Between December and February, vaccinations to prevent measles jumped 27 percent compared with the same period last year in Washington. A high-profile outbreak at Disneyland may have contributed, health officials said. (Aleccia, 4/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优